South African Firm to Help Develop COVID-19 Vaccines for the Rest of Africa
The Biovac Institute, a South African vaccine company, is formulating expansion plans aimed at helping Africa become more self-sufficient when its comes to accessing the immunising shots.
The coronavirus outbreak has highlighted the continent’s reliance on imported vaccines, with limited shot-making facilities only present in South Africa, Senegal and Egypt.
Biovac, which is 47.5% state-owned, is in talks to produce a Covid-19 vaccine at its facilities, and Aspen Pharmacare Holdings Ltd. has agreed to make Covid-19 shots on behalf of Johnson & Johnson at a facility in the southern city of Port Elizabeth.
Photo courtesy of Daniel Schludi.